The manuscript studies the release kinetic of fluorescein from colloidal liquid crystals 
Introduction

37
The release kinetic of drugs from pharmaceutical formulations plays a main role to study the 38 biopharmaceutical features of payloads following their administration into the body [1] . In fact, the 39 process of release of a drug from formulations can modulate its absorption into the various 40 biological compartments; besides its distribution and plasma concentration, that is the rate of 41 absorption and bioavailability in biological fluids [2] . In this attempt, technological approaches are 42 extensively used to design pharmaceutical formulations and to obtain a controlled release of drugs.
43
Furthermore, drug release is affected by different physiological parameters, e.g. pH of the gastric coefficient of permeation and diffusion may be also affect the release profile of drug delivery 48 systems [4, 5] .
49
The release profile of drugs and bio-molecules from conventional and innovative carriers, such 50 as monoglyceride colloidal liquid crystals, could be described using mathematical approaches. In 
61
In this attempt, preliminary in vitro experiments needed to evaluate the release profile of 62 payloads from monoglyceride colloidal liquid crystals and to predict their potential in vivo behavior.
63
The prediction of physicochemical properties in colloidal formulations can be investigated using 64 mathematical models that suitable describe the potential in vitro/in vivo trend [10, 11] .
65
The massive release kinetics of drugs resulting from the experimental data were further 66 described using different mathematical models such as Noyes 
105
The release of fluorescein from monoglyceride colloidal liquid crystals was investigated using 106 dialysis membrane. Regenerated cellulose membrane with molecular cut-off 25,000 Dalton
107
(Spectra/Por Membranes, Spectrum Laboratories, Inc., CA, USA) was used for release experiments.
108
Membrane was hydrated before analysis for 40 min using a sterile isotonic saline solution to remove 
118
where, x represents the fluorescein concentration (µg/ml) and y the UV/Vis absorbance (nm).
119
The 
175
The flux J of molecule through virtual interfaces in solution was described using Fick's first law:
176 177 
215
By accepting the assumption that beyond the limit layer of particle narrow size distribution, the 
220
Noyes-Whitney law represents a model having a single parameter k.
221
Sometimes solvents penetrate or swell through the pharmaceutical formulations. In such cases,
222
the representation is a straight line, kt α + , without passing through the origin. In this case, the 223 model has two parameters, α and k, and it is, in fact, no longer then a solution where
224
Noyes-Whitney law can be applied using the same initial conditions. If α is considered as a time 225 lag, it is possible to simplify the Noyes-Whitney law.
226
When the release occurred into medium having a constant volume V and release was reported 
250
This equation allows analyzing α as the scale factor and β as the shape factor in the Weibull 251 distribution.
252
The following transformation is then used to describe the following equation: 
306
The different solutions of Fick's second law depend on the initial and boundary conditions. In 
396
The law is semi-empirical and represents a generalization of Higuchi's law. 
412
In particular, for diffusion process, a symbol is reported as D.
413
The experimental amount of released drug is proportional to t or t or t t ; these data can 414 be interpreted as one-dimensional, two-dimensional or three-dimensional diffusion processes. 
445
conditions in solving the Fick's second law of diffusion [28] . Recent data showed that this model 
452
The drug release kinetic is also affected by the composition of carriers and technological 453 parameters, such as excipients, biomaterials, drug loading, geometry, size and shape. Furthermore,
454
for conventional formulations, the amount of drug measured in the dissolution medium depends 455 both on the payloads released in the receptor medium and the bulk of drug, which is still 456 un-dissociated from formulations [3] . In particular, the amount of drugs contained in the 457 un-dissociated formulations could be also used to describe their release kinetic.
458
The extrapolation of theoretical criteria, herein reported for conventional formulations, allowed 
Description and analysis of obtained release kinetics
465
The release kinetic of fluorescein, which is used as a hydrophilic drug candidate, from different 466 monoglyceride colloidal liquid crystals was investigated as a function of liquid crystal compositions 467 (Table 1) . As shown in Figure 1 , surfactants forming colloidal liquid crystals affect the release kinetic (Figures 2a and b, respectively) . 
507
Furthermore, the r 2 value obtained by using the Peppas model for data analysis was 0.988; 
531
The mathematical analysis of formulation 2 showed that the release profile of fluorescein using 
541
Results obtained using statistical criteria did not allow having the best model describing the 542 release kinetic between those herein reported. 
550
No significant difference was obtained by using the F-test analysis with the models previously 551 reported. In particular, the F-test demonstrated that the Peppas model seemed to be more significant 552 than the other models (Figure 3a) . In fact, the r 2 value was 0.991 and all points of analysis fitted with 
557
The Imbimbo comparison of Higuchi and Weibull models of the release kinetic profile of 558 formulation 2 did not show any significant difference ( 
567
The release profile of formulation 3 showed that fluorescein was rapidly released from 
586
All models fitted data in the first 6 h, except Peppas and Weibull models, could be applied on 587 the full range of analysis. Any suitable result was obtained when the Noyes-Whitney model was
588
applied for the analysis of formulation 3 (Figure 4e ).
589
The mathematical analysis of the release profile of formulation 4 showed that the 
605
Noyes-Whitney. Data represented the average of three different measurements ± standard deviation.
607
Different results were obtained for formulation 5. In this case, the Higuchi model showed that a 608 specific fitting occurred when the analysis was carried out up to 20 h of incubation ( Figure 6 ).
609
Theoretical and experimental analysis are strictly correlated by applying the Higuchi model. Any 
618
Error bar if not reported was included in the symbol.
620
Results showed that by applying the square root model data theoretical and experimental data 621 fitted enough for five different formulations; and was allowed to improve the statistical significance 
634
Results obtained by using mathematical models could be used to predict the release profile 635 from supramolecular carriers. These mathematical models could also be applied to validate the 636 obtained results.
637
Our findings showed that a square root model represented most efficacious mathematical 
